Literature DB >> 18307025

A Japanese patient with Li-Fraumeni syndrome who had nine primary malignancies associated with a germline mutation of the p53 tumor-suppressor gene.

Naohiro Izawa1, Seiichi Matsumoto, Jun Manabe, Taisuke Tanizawa, Manabu Hoshi, Toshio Shigemitsu, Rikuo Machinami, Hiroaki Kanda, Kengo Takeuchi, Yoshio Miki, Masami Arai, Shuya Shirahama, Noriyoshi Kawaguchi.   

Abstract

We describe a patient who had nine primary malignant tumors and a germline mutation in the p53 tumor-suppressor gene, characteristically found in the Li-Fraumeni syndrome (LFS). A 15-year-old girl with no family history of cancer was referred to our hospital because of pain and swelling of the right knee. Osteosarcoma was diagnosed. The patient received chemotherapy followed by surgery and had a remission. After the age of 28 years, nine primary malignant tumors developed successively, including right breast cancer, colon cancer, malignant fibrous histiocytoma (MFH) of the abdominal wall, right lung double cancers, bilateral breast cancers, and MFH of the left thigh. This is the second highest number of types of primary malignant tumors to be reported in LFS. All tumors were treated by a multidisciplinary approach, including surgery. Genetic analysis revealed a germline missense mutation in the p53 gene (c.659 A > G), resulting in Y220C, which has been reported in three families with LFS. The patient died of lung metastasis from MFH at the age of 37 years. Despite the multiple tumors, repeated induction of remissions resulted in long survival. Our findings suggest that a multidisciplinary approach to treatment, including surgery, is beneficial in patients with LFS.

Entities:  

Mesh:

Year:  2008        PMID: 18307025     DOI: 10.1007/s10147-007-0692-8

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  15 in total

1.  Multiple primary cancers in families with Li-Fraumeni syndrome.

Authors:  M Hisada; J E Garber; C Y Fung; J F Fraumeni; F P Li
Journal:  J Natl Cancer Inst       Date:  1998-04-15       Impact factor: 13.506

2.  Soft-tissue sarcomas, breast cancer, and other neoplasms. A familial syndrome?

Authors:  F P Li; J F Fraumeni
Journal:  Ann Intern Med       Date:  1969-10       Impact factor: 25.391

3.  Germline mutations of p53 but not p16/CDKN2 or PTEN/MMAC1 tumor suppressor genes predispose to gliomas. The ANOCEF Group. Association des NeuroOncologues d'Expression Française.

Authors:  X P Zhou; M Sanson; K Hoang-Xuan; E Robin; L Taillandier; J He; K Mokhtari; P Cornu; J Y Delattre; G Thomas; R Hamelin
Journal:  Ann Neurol       Date:  1999-12       Impact factor: 10.422

Review 4.  A patient with 17 primary tumours and a germ line mutation in TP53: tumour induction by adjuvant therapy?

Authors:  C Nutting; R S Camplejohn; R Gilchrist; D Tait; P Blake; G Knee; W Q Yao; G Ross; C Fisher; R Eeles
Journal:  Clin Oncol (R Coll Radiol)       Date:  2000       Impact factor: 4.126

5.  Germ-line TP53 mutations in Finnish cancer families exhibiting features of the Li-Fraumeni syndrome and negative for BRCA1 and BRCA2.

Authors:  P Huusko; K Castrén; V Launonen; Y Soini; K Pääkkönen; J Leisti; K Vähäkangas; R Winqvist
Journal:  Cancer Genet Cytogenet       Date:  1999-07-01

Review 6.  Genetic predictors for drug resistance in soft tissue sarcoma: a review of publications in 2004.

Authors:  Jérôme Fayette; Jean-Yves Blay
Journal:  Curr Opin Oncol       Date:  2005-07       Impact factor: 3.645

Review 7.  Germline TP53 mutations and Li-Fraumeni syndrome.

Authors:  J M Varley
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

Review 8.  The UMD-p53 database: new mutations and analysis tools.

Authors:  Christophe Béroud; Thierry Soussi
Journal:  Hum Mutat       Date:  2003-03       Impact factor: 4.878

9.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

10.  Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families.

Authors:  J M Birch; A L Hartley; K J Tricker; J Prosser; A Condie; A M Kelsey; M Harris; P H Jones; A Binchy; D Crowther
Journal:  Cancer Res       Date:  1994-03-01       Impact factor: 12.701

View more
  9 in total

Review 1.  Breast Cancer and Multiple Primary Malignant Tumors: Case Report and Review of the Literature.

Authors:  Alessandro De Luca; Federico Frusone; Massimo Vergine; Rosario Cocchiara; Giuseppe La Torre; Laura Ballesio; Massimo Monti; Maria Ida Amabile
Journal:  In Vivo       Date:  2019 Jul-Aug       Impact factor: 2.155

2.  Pleomorphic carcinoma of the lung arising in a patient with Li-Fraumeni syndrome: report of a case.

Authors:  Tatsuya Kato; Keidai Ishikawa; Masaaki Satoh; Satoshi Kondo; Mitsuhito Kaji
Journal:  Surg Today       Date:  2011-05-28       Impact factor: 2.549

3.  Multifocal osteosarcoma in childhood.

Authors:  Beate Kunze; Steffen Bürkle; Torsten Kluba
Journal:  Chir Organi Mov       Date:  2009-04-28

Review 4.  Tumor protein p53 (TP53) testing and Li-Fraumeni syndrome : current status of clinical applications and future directions.

Authors:  April D Sorrell; Carin R Espenschied; Julie O Culver; Jeffrey N Weitzel
Journal:  Mol Diagn Ther       Date:  2013-02       Impact factor: 4.074

5.  Surgery for Li Fraumeni syndrome: pushing the limits of surgical oncology.

Authors:  Russell C Langan; Kiran H Lagisetty; Scott Atay; Prakash Pandalai; Alexander Stojadinovic; Udo Rudloff; Itzhak Avital
Journal:  Am J Clin Oncol       Date:  2015-02       Impact factor: 2.339

6.  Breast Cancer Patient with Li-Fraumeni Syndrome: A Case Report Highlighting the Importance of Multidisciplinary Management.

Authors:  Beatriz Cirauqui; Teresa Morán; Anna Estival; Vanesa Quiroga; Olatz Etxaniz; Carmen Balana; Matilde Navarro; Salvador Villà; Rosa Ballester; Mireia Margelí
Journal:  Case Rep Oncol       Date:  2020-02-13

Review 7.  Hereditary ovarian cancer: not only BRCA 1 and 2 genes.

Authors:  Angela Toss; Chiara Tomasello; Elisabetta Razzaboni; Giannina Contu; Giovanni Grandi; Angelo Cagnacci; Russell J Schilder; Laura Cortesi
Journal:  Biomed Res Int       Date:  2015-05-17       Impact factor: 3.411

8.  The Features of Colorectal Tumors in a Patient with Li-Fraumeni Syndrome.

Authors:  Tsukasa Yoshida; Masahiro Tajika; Tsutomu Tanaka; Makoto Ishihara; Yutaka Hirayama; Nobumasa Mizuno; Kazuo Hara; Susumu Hijioka; Hiroshi Imaoka; Nobuhiro Hieda; Nozomi Okuno; Takashi Kinoshita; Vikram Bhatia; Yasuhiro Shimizu; Yasushi Yatabe; Kenji Yamao; Yasumasa Niwa
Journal:  Intern Med       Date:  2017-02-01       Impact factor: 1.271

9.  Characteristics of Li-Fraumeni Syndrome in Japan; A Review Study by the Special Committee of JSHT.

Authors:  Michinori Funato; Yukiko Tsunematsu; Fumito Yamazaki; Chieko Tamura; Tadashi Kumamoto; Masatoshi Takagi; Shunsuke Kato; Haruhiko Sugimura; Kazuo Tamura
Journal:  Cancer Sci       Date:  2021-05-01       Impact factor: 6.716

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.